Xconomy | Boston - Business + Technology in the Exponential Economy

Aveo Pharmaceuticals, Inc. Lands $30,000,000 New Financing

  • Feed Type
  • Date
    4/10/2009
  • Company Name
    Aveo Pharmaceuticals, Inc.
  • Mailing Address
    75 Sidney Street Cambridge, MA 02139
  • Company Description
    AVEO is a biopharmaceutical company focused on the discovery and development of novel cancer therapeutics. AVEO is developing a pipeline of targeted therapies which address major unmet medical needs in the field of oncology. The Company utilizes its proprietary in vivo cancer models for the identification and validation of novel drug targets and to guide the development of its products.
  • Website
    http://www.aveopharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.